BioLargo Research and Development Expenses 2010-2024 | BLGO

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

BioLargo research and development expenses from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.

BioLargo Research and Development Expenses 2010-2024 | BLGO

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

BioLargo research and development expenses from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.

Related Stocks
Company Name	Market Cap
Quanta Services (PWR)	$48.9B
Alfa Laval AB (ALFVY)	$18.2B
AECOM (ACM)	$14.8B
KBR (KBR)	$9.5B
Altair Engineering (ALTR)	$8.8B
Fluor (FLR)	$8.7B
Amentum Holdings (AMTM)	$8.3B
Arcadis (ARCAY)	$6.2B
Sterling Infrastructure (STRL)	$6B
ChampionX (CHX)	$5.9B
VSE (VSEC)	$2.4B
SENIOR (SNIRF)	$700M
Chiyoda (CHYCY)	$523M
Mayville Engineering (MEC)	$354M
TSS (TSSI)	$218M
WANG & LEE GROUP (WLGS)	$53M
Harris & Harris (TURN)	$33M
SUs (SUGP)	$20M
ENGlobal (ENG)	$7M
CEA Industries (CEAD)	$5M
SKK Holdings (SKK)	$0M